Jpmorgan Chase & Co »

Vaneck Vectors Pharmaceutical etf shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $13M 158k 81.37
2023-09-30 $16M 203k 79.86
2023-06-30 $4.2M 53k 78.77
2023-03-31 $4.0M 51k 77.64
2022-12-31 $46k 588 78.23
2019-09-30 $5.7M 101k 56.89
2019-06-30 $51k 880 57.95
2019-03-31 $53k 880 60.23
2018-12-31 $98k 1.8k 54.84
2018-09-30 $120k 1.9k 64.21
2018-06-30 $115k 1.9k 59.00
2018-03-31 $111k 1.9k 56.95
2017-12-31 $116k 1.9k 59.52
2017-06-30 $136k 2.3k 59.16
2017-03-31 $124k 2.2k 55.14
2016-12-31 $13M 252k 52.51
2016-09-30 $133k 2.3k 57.68
2016-06-30 $175k 3.0k 58.45